NATCO Pharma Ltd. — documents
173 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_35548_10828_23052018092912_WEB.xml | 9f5841df531326c6 |
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_35549_10830_23052018093228_WEB.xml | ae1ef08d3a71a872 |
| Results XBRL (NSE) | 2018-06-30 | Consolidated | — | INDAS_38072_32589_08082018060101_WEB.xml | a61afa664f55869a |
| Results XBRL (NSE) | 2018-06-30 | Standalone | — | INDAS_38073_32599_08082018060713_WEB.xml | eebd31cb455852fc |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40405_58358_06112018064125_WEB.xml | bf8598ff8e131e2e |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40408_58365_06112018064613_WEB.xml | e16ea286c98e7489 |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_42875_81667_12022019045745_WEB.xml | d33e7d75edc50c4a |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_42879_81677_12022019050226_WEB.xml | 1691a00812f8afa0 |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_44916_104678_27052019070352_WEB.xm | 5de1360bc87b81a0 |
| Results XBRL (NSE) | 2019-03-31 | Consolidated | — | INDAS_44917_104682_27052019071020_WEB.xm | a84a2d775581d676 |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_47172_129706_09082019063243_WEB.xm | 1fcf0d304fd533f5 |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_47174_129713_09082019063828_WEB.xm | 4f6ecf0e63b8ce1f |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_50001_164868_12112019043841_WEB.xm | d7f0b751c079cd80 |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_50002_164871_12112019044002_WEB.xm | 538b3121877b17fa |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_53560_219314_12022020051642_WEB.xm | 85a30c5057bfbc02 |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_53564_219333_12022020052039_WEB.xm | bd29e012612c3859 |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55961_266021_17062020050159_WEB.xm | 65a601085f75ba8b |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55962_266027_17062020050443_WEB.xm | f3c6ed3aba93cb93 |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_59973_305793_12082020052510_WEB.xm | 919dec49a477831f |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_59975_305802_12082020052704_WEB.xm | 92c7b10a65ece110 |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_64828_360925_12112020060032_WEB.xm | b031800a540953e6 |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_64835_360946_12112020060620_WEB.xm | 5f75ff7226e7ddc4 |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67963_406041_11022021040411_WEB.xm | 850af41da0a0ae52 |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67968_406053_11022021040536_WEB.xm | 720569426869b7d2 |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_71423_460430_17062021065546_WEB.xm | 7df54ce7c42fdb8a |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_71424_460433_17062021065720_WEB.xm | 7de1096f1640ed10 |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_75126_504486_12082021051026_WEB.xm | ec18fa0c3e2bce61 |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_75131_504508_12082021051902_WEB.xm | 7fdbc8f04048fe69 |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_78377_554536_11112021043536_WEB.xm | 077db2abca27e9d0 |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_78378_554542_11112021043644_WEB.xm | 047a95fc5bb6bf17 |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_82962_610386_14022022061850_WEB.xm | d368cbb2eab3b176 |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_82966_610408_14022022062941_WEB.xm | 97962c52b8ca101d |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_86574_668908_31052022120431_WEB.xm | 63c9ea00e96df272 |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_86575_668913_31052022120640_WEB.xm | fcd9e3a00c96b1b4 |
| Results XBRL (NSE) | 2022-06-30 | Consolidated | — | INDAS_642215_2657_09082022175057_WEB.xml | 678e923b5ac9bc1b |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_642231_2657_09082022175244_WEB.xml | 14556ac82e6c41d7 |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_854058_4998_10112022162327_WEB.xml | 0d6db728490170cc |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_854066_4998_10112022162359_WEB.xml | f7299d3e5b55acb8 |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_89155_789613_09022023034535.xml | 7dfe0aca0ff6076b |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_89156_789617_09022023034646.xml | 30b6b553f7d738c3 |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_93382_857038_29052023100443.xml | ae951d1796dfa1f5 |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_93383_857041_29052023100647.xml | 18ab12eb38c36a05 |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95896_912071_09082023050324.xml | 9b834e93831a5b9a |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95897_912078_09082023050559.xml | 76d41ecdfdf0ea41 |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100797_988006_14112023043703.xml | 87cf94ae3a87f8b8 |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100798_988010_14112023043829.xml | ac821ced990800be |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_104159_1055393_14022024052355.xml | 29d2a54a939f35f2 |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_104162_1055406_14022024052730.xml | 8cc84a537482efe0 |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107331_1140116_27052024050639.xml | 42db6d4502297eb1 |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107333_1140124_27052024050822.xml | 8265e8cfdc6018ff |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_111402_1221165_12082024040949.xml | 473546606f8434df |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_111405_1221185_12082024041245.xml | c9a011ef5d4e6d9c |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_115095_1305660_12112024034035.xml | 6a894eaf9d6279d8 |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_115097_1305666_12112024034230.xml | cf151816e7b961a9 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_119894_1379844_12022025044333.xml | 37724fe7693333d6 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_119898_1379856_12022025044609.xml | 680e44964ea24d2a |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1454901_28052025 | 9f4d5c1bb814ebc8 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1454905_28052025 | e32f7f230f8eca73 |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1509408_12082025 | d148a9a07d886d39 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1509409_12082025 | 64cd82401f91e2a7 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1574886_14112025 | 0e895416e76a4a10 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1574887_14112025 | 37faf2b023be3be2 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1624147_12022026 | 229f0eb090bc33be |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1624148_12022026 | d394cd51587af130 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1676118_29052026 | e9fef9a2ab00707a |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1676129_29052026 | 50de406140f3cba6 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1714409_14082026 | 8a9796beac5a1779 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1714414_14082026 | 4ae02cc364302274 |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-08T17:29:29 | Main_Ind_As_524816_88201817288.xml | 7f8f7a58f463d511 |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-08T17:29:29 | Main_Ind_As_524816_882018172919.xml | 10d981a0c2e2f30b |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-06T18:27:58 | Main_Ind_As_524816_6112018182552.xml | 31d6de19094e5780 |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-06T18:27:58 | Main_Ind_As_524816_6112018182740.xml | 0253dc73ecbecfe2 |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-12T16:30:23 | Main_Ind_As_524816_1222019162935.xml | 14df5a97cca94e15 |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-02-12T16:30:23 | Main_Ind_As_524816_1222019163127.xml | dda6fd4d07e0ead2 |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-27T16:56:04 | Main_Ind_As_524816_2752019165543.xml | 6e03e24b021e0139 |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-27T16:56:04 | Main_Ind_As_524816_2752019165735.xml | 2cdf2974ac6c93b4 |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-08-09T18:23:38 | Main_Ind_As_524816_982019182329.xml | f61bc274bbe0632a |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-08-09T18:23:38 | Main_Ind_As_524816_982019182358.xml | 0d6e70078cd3ff53 |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-11-12T16:19:02 | Main_Ind_As_524816_12112019161820.xml | fd978abacf42cdb3 |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-11-12T16:19:02 | Main_Ind_As_524816_12112019161942.xml | 355ed3b2a8108dd5 |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-12T17:12:37 | Main_Ind_As_524816_1222020171218.xml | 3ef0fff02f732a89 |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-12T17:12:37 | Main_Ind_As_524816_1222020171255.xml | 4bb8b84452aefd5b |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-06-17T17:10:46 | Main_Ind_As_524816_1762020171017.xml | ad9ead76968177fd |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-06-17T17:10:46 | Main_Ind_As_524816_1762020171110.xml | 6b7f73cbd6110215 |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-08-12T17:21:30 | Main_Ind_As_524816_1282020172025.xml | 1db99d65bc2e260a |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-08-12T17:21:30 | Main_Ind_As_524816_1282020172119.xml | a28372d2b9f9e75b |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-11-12T17:56:18 | Main_Ind_As_524816_12112020175540.xml | 5a1b2fc62bb98a90 |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-11-12T17:56:18 | Main_Ind_As_524816_12112020175630.xml | be261b43ef30116c |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-11T15:43:53 | Main_Ind_As_524816_1122021154252.xml | 255f5babcfb40157 |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-11T15:43:53 | Main_Ind_As_524816_1122021154330.xml | 18dee9482fd9c0a6 |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-06-17T18:52:28 | Main_Ind_As_524816_1762021184923.xml | 05b849a78607d03b |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-06-17T18:52:28 | Main_Ind_As_524816_1762021185136.xml | d09381843803a766 |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-08-12T17:07:57 | Main_Ind_As_524816_128202117634.xml | 70139cfdef731745 |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-08-12T17:07:57 | Main_Ind_As_524816_128202117736.xml | 3548f67236f666d5 |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-11-11T16:34:10 | Main_Ind_As_524816_1111202116327.xml | 588c1e38fae72965 |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-11-11T16:34:10 | Main_Ind_As_524816_11112021163323.xml | 104fd1a012e80927 |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-14T18:11:57 | Main_Ind_As_524816_1422022181015.xml | b9b6a0578ef026c4 |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-14T18:11:57 | Main_Ind_As_524816_1422022181134.xml | 39c677ed3024bebf |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-31T16:16:28 | Main_Ind_As_524816_3052022235926.xml | 898e58c71d4dc31b |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-31T16:16:28 | Main_Ind_As_524816_31520220051.xml | 2b60cf661c78870c |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-08-10T13:15:40 | Main_Ind_As_524816_98202217428.xml | 678e923b5ac9bc1b |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-08-10T13:15:40 | Main_Ind_As_524816_982022174312.xml | 14556ac82e6c41d7 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-10T18:22:30 | Main_Ind_As_524816_10112022161842.xml | f7299d3e5b55acb8 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-10T18:22:30 | Main_Ind_As_524816_1011202216208.xml | 0d6db728490170cc |
| Annual report | 2016-03-31 | grade A | 2016-10-01T00:00:00 | 5248160316.pdf | 5cbbf558a53740cc |
| Annual report | 2017-03-31 | grade A | 2017-10-03T00:00:00 | 5248160317.pdf | 01ff77d591a835d1 |
| Annual report | 2018-03-31 | grade A | 2018-09-18T00:00:00 | 5248160318.pdf | d5959def2202d644 |
| Annual report | 2019-03-31 | grade A | 2019-08-09T00:00:00 | 5248160319.pdf | c68805c03a50566c |
| Annual report | 2020-03-31 | grade A | 2020-09-18T00:00:00 | 67194524816.pdf | 7fc4143b4b3ba006 |
| Annual report | 2021-03-31 | grade A | 2021-09-02T00:00:00 | 70606524816.pdf | 054bef1303e631e9 |
| Annual report | 2022-03-31 | grade A | 2022-09-02T00:00:00 | 75411524816.pdf | 09761254b92cbda8 |
| Annual report | 2023-03-31 | grade A | 2023-09-04T20:27:56.493 | 76692336-a42d-46bd-aa85-16fbb9846663.pdf | 6e71e5cbcb3df86e |
| Annual report | 2024-03-31 | grade A | 2024-09-04T18:01:54.19 | d5a992a3-1b5a-44b4-8e5b-343b600e56fc.pdf | 3938287b47252805 |
| Annual report | 2025-03-31 | grade A | 2025-08-29T18:10:46.593 | 08737473-9fef-496b-881b-746b8ab600b1.pdf | a959375e52d3dbff |
| Annual report | 2026-03-31 | grade A | 2026-09-04T20:11:52.41 | 0d25dc00-4a7e-4acc-b5a8-d747c870ab2f.pdf | b2dec4aa9d1f7b4e |
| Concall | 2021-06-30 | TRANSCRIPT | — | Date_20220817_NATCO Pharma Ltd._Concal_Q1FY22.pdf | b801ffa822e999f9 |
| Concall | 2022-03-31 | COVER_LETTER | — | Date_20220531_NATCO Pharma Ltd._Concal_Q4FY22.pdf | b013252fe13d6380 |
| Concall | 2022-03-31 | TRANSCRIPT | — | Date_20220604_NATCO Pharma Ltd._Concal_Q4FY22.pdf | eb55593184a79f90 |
| Concall | 2022-06-30 | COVER_LETTER | — | Date_20220810_NATCO Pharma Ltd._Concal_Q1FY23_Audio.pdf | f07bac417d851060 |
| Concall | 2022-09-30 | COVER_LETTER | — | Date_20221111_NATCO Pharma Ltd._Concal_Q2FY23_Audio.pdf | c9f687707c624939 |
| Concall | 2022-12-31 | COVER_LETTER | — | Date_20230210_NATCO Pharma Ltd._Concal_Q3FY23_Audio.pdf | f4784867b6f25472 |
| Concall | 2022-12-31 | TRANSCRIPT | — | Date_20230213_NATCO Pharma Ltd._Concal_Q3FY23.pdf | 88babbcfd6170b3c |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230530_NATCO Pharma Ltd._Concal_Q4FY23_Audio.pdf | dca0e850b1fca919 |
| Concall | 2023-03-31 | TRANSCRIPT | — | Date_20230601_NATCO Pharma Ltd._Concal_Q4FY23.pdf | 70cc5fb420f22d18 |
| Concall | 2023-06-30 | COVER_LETTER | — | Date_20230810_NATCO Pharma Ltd._Concal_Q1FY24_Audio.pdf | 8356f0df48ddf1f4 |
| Concall | 2023-06-30 | TRANSCRIPT | — | Date_20230814_NATCO Pharma Ltd._Concal_Q1FY24.pdf | 1e1a2344388dbf50 |
| Concall | 2023-12-31 | TRANSCRIPT | — | Date_20240221_NATCO Pharma Ltd._Concal_Q3FY24.pdf | e369c631652cf3c9 |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20240604_NATCO Pharma Ltd._Concal_Q4FY24.pdf | cd5b743ada50c84d |
| Concall | 2024-03-31 | TRANSCRIPT | — | Date_20250604_NATCO Pharma Ltd._Concal_Q4FY24.pdf | fa1598732492dc8a |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240813_NATCO Pharma Ltd._Concal_Q1FY25.pdf | ec24b7e66f0d5646 |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240813_NATCO Pharma Ltd._Concal_Q1FY25_Audio.pdf | 64a6dc475564c2e8 |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240813_NATCO Pharma Ltd._Notice_Notice.pdf | b65c10833f3ace1a |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240821_NATCO Pharma Ltd._Concal_Q1FY25.pdf | 14997c14ea0a64bf |
| Concall | 2024-06-30 | DUPLICATE | — | Date_20240821_NATCO Pharma Ltd._Concal_Q1FY25_v2.pdf | ec24b7e66f0d5646 |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20250819_NATCO Pharma Ltd._Concal_Q1FY25.pdf | 0b0011fd1803514f |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241121_NATCO Pharma Ltd._Concal_Q2FY25.pdf | bbb42620f63d352d |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20251115_NATCO Pharma Ltd._Concal_Q2FY25.pdf | 719ae265d75db4ac |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20251115_NATCO Pharma Ltd._Notice_Q2FY25.pdf | 1f1fee16e2ab114e |
| Concall | 2024-12-31 | TRANSCRIPT | — | Date_20250219_NATCO Pharma Ltd._Concal_Q3FY25.pdf | 32d86963501d7abb |
| Concall | 2025-06-30 | ANALYST_MEET | — | Date_20250724_NATCO Pharma Ltd._Concal_Recovered.pdf | b8d23df295b05cd7 |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20250724_NATCO Pharma Ltd._Notice_Notice.pdf | e2222e592c916f41 |
| Concall | 2025-06-30 | DUPLICATE | — | Date_20250729_NATCO Pharma Ltd._Concal_Q1FY26.pdf | 22ab033ce3ae3010 |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20260814_NATCO Pharma Ltd._Concal_Q1FY26.pdf | b26b1b05d8da4cbc |
| Concall | 2025-06-30 | DUPLICATE | — | Date_20260818_NATCO Pharma Ltd._Concal_Q1FY26.pdf | ee0ce48ea7fe4856 |
| Concall | 2025-09-30 | DUPLICATE | — | Date_20251120_NATCO Pharma Ltd._Concal_Q2FY26.pdf | 48008ed39e269b70 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260604_NATCO Pharma Ltd._Concal_Q4FY26.pdf | e2036b6ccc2591b7 |
| Concall | 2026-03-31 | DUPLICATE | — | Date_20260604_NATCO Pharma Ltd._Concal_Q4FY26_v2.pdf | fd47f4a75e04b642 |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260814_NATCO Pharma Ltd._Concal_Q1FY27.pdf | 0a9d4b473b6058d5 |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161086_525495_08102021042704_WEB.xml | 30b91e7b89c80183 |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164223_584426_12012022024041_WEB.xml | af930c93280fc11a |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166822_633937_13042022042151_WEB.xml | da553d7b14079a5c |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169732_692034_18072022094328_WEB.xml | 69c656004fc86863 |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171233_727525_15102022121834_WEB.xml | eb4c1163ef9fa295 |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_173637_759897_10012023120526_WEB.xml | 461e55e640164f5d |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176015_812434_10042023025736_WEB.xml | 61dfc7833ca21544 |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_178741_882375_13072023115048_WEB.xml | 325430d90673b82b |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_180930_945361_10102023041159_WEB.xml | 6cd50332d0c9d11c |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183362_1010369_08012024031312_WEB.xm | 6f96481060238d53 |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_186509_1089824_12042024050213_WEB.xm | 73963fdd46f32111 |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_188978_1178430_10072024044528_WEB.xm | 2d79007b0f9745ae |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191820_1267923_14102024024421_WEB.xm | 175c47e0b32f1776 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_193987_1398143_20032025025533_WEB.xm | 5599b69ae5a46aef |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197335_1415362_16042025104507_WEB.xm | af5e48da348a9c58 |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1482950_15072025022733_WEB.xml | 644a0dddb3b45f9c |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1543722_09102025062609_WEB.xml | f2408147564181c1 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1603978_19012026020157_WEB.xml | c8b28f8cca848e92 |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1647709_09042026102912_WEB.xml | 19e13bdbeab1d6ed |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1689944_09072026054425_WEB.xml | 58d4f04e0b903f96 |
| Related-party XBRL | 2022-09-30 | — | — | RPT_NATCOPHARM_22112022162058.xml | 9e0f5563ca068360 |
| Related-party XBRL | 2023-03-31 | — | — | RPT_856234_29052023041949_WEB.xml | 0e2d6192ef5f2da4 |
| Related-party XBRL | 2023-09-30 | — | — | RPT_988013_14112023044009_WEB.xml | 459dc978cea98b25 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1140226_27052024053539_WEB.xml | 30424f2b8a370302 |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1305948_12112024044055_WEB.xml | c4a4c0ab25944469 |